Science Explorer Back to mapMap
Discussion
Researcher · Leitat Technological Center · Spain

J. Gilabert

J. Gilabert publishes mostly in Hematology, Obstetrics and Gynecology and Molecular Biology, on topics such as Blood Coagulation and Thrombosis Mechanisms, Pregnancy and preeclampsia studies and Protease and Inhibitor Mechanisms.

ORCID 0000-0003-2717-1718 OpenAlex
World rank
#4,011,329
of 7,710,434 ranked researchers
Rank in Spain
#91,625
of 204,306
Works
85
Citations
2.2k
Citations per work
25.4
h-index
27
i10-index 44Top 14% in Hematology
J. Gilabert

What does J. Gilabert research?

J. Gilabert's work is mostly in Medicine (33%), Biochemistry, Genetics and Molecular Biology (16%), Neuroscience (5%).

Everything else: 39 works · 46.1% of their workHealth Sciences: 28 works · 32.9% of their workMedicine: 28 works · 32.9% of their workHematology: 15 works · 17.8% of their workObstetrics and Gynecology: 9 works · 11.0% of their workPulmonary and Respiratory Medicine: 3 works · 4.1% of their workLife Sciences: 18 works · 21.0% of their workBiochemistry, Genetics and Molecular Biology: 14 works · 16.4% of their workMolecular Biology: 8 works · 10.0% of their workCancer Research: 5 works · 6.4% of their workNeuroscience: 4 works · 4.6% of their workCellular and Molecular Neuroscience: 4 works · 4.6% of their workTHEIR WORKJ. Gilabert85works
Life Sciences21%Health Sciences33%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3946.1%
    1. Medicine2832.9%
    1. Biochemistry, Genetics and Molecular Biology1416.4%
    2. Neuroscience44.6%
  1. 1Hematology18% of their works
  2. 2Obstetrics and Gynecology11% of their works
  3. 3Molecular Biology10% of their works
  4. 4Cancer Research6% of their works
  5. 5Cellular and Molecular Neuroscience5% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe J. Gilabert's research?

The keywords of their largest research topics: Hemostasis, Antithrombotic Therapy, Protease-Activated Receptors, Thrombin, Cell Signaling, Placental Development, Preeclampsia and Matrix Metalloproteinases.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Hemostasis422 topics
  2. Antithrombotic Therapy412 topics
  3. Protease-Activated Receptors351 topic
  4. Thrombin351 topic
  5. Cell Signaling273 topics
  6. Placental Development201 topic
  7. Preeclampsia201 topic
  8. Matrix Metalloproteinases141 topic
  9. Tissue Inhibitors of Metalloproteinases141 topic
  10. Ion Channels91 topic
  11. Voltage-Gated Channels91 topic
  12. Fibrinogen71 topic
  13. Transglutaminases71 topic
  14. Pulmonary Embolism61 topic
  15. Venous Thromboembolism61 topic
  16. Crystal Structure41 topic
  17. G-Protein-Coupled Receptors41 topic
  18. Neurotransmission41 topic
  19. Synaptic Plasticity41 topic

Where does J. Gilabert work?

J. Gilabert's main affiliation in the publication record is Leitat Technological Center, Spain.

How many publications and citations does J. Gilabert have?

OpenAlex counts 85 works and 2,161 citations for J. Gilabert, an h-index of 27, ranking #4,011,329 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about J. Gilabert. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.